Targeted therapy has officially entered the first-line standard of care for a high-risk molecular subset of metastatic colorectal cancer (mCRC).…
Browsing: Clinical Updates
Virtual multidisciplinary GI care is moving from pilot data to scaled performance metrics. Oshi Health released its 2025 Impact Report,…
A large Swedish randomized trial (SCREESCO), published in Nature Medicine, evaluated over 278,000 60-year-olds assigned to: Unlike most prior trials,…
The third week of February brings a wide-ranging set of updates across GI oncology, reflecting continued progress in both biological…
The FORTE trial is a large randomized clinical study evaluating whether patients with 1–2 non-advanced adenomatous polyps benefit from earlier…
Multi-cancer early detection (MCED) blood tests continue to face clinical validation challenges after Grail’s Galleri test failed to meet its…
Stool-based screening remains a cornerstone of colorectal cancer prevention, with randomized trials showing that screening can reduce CRC incidence by…
New research presented at the 2026 Crohn’s & Colitis Congress® highlights a rapidly evolving therapeutic landscape in inflammatory bowel disease…
For years, gut health has been used liberally across research papers, probiotic marketing campaigns, and patient conversations—often without a consistent…
Despite the introduction of more specific ICD-10-CM codes for short bowel syndrome (SBS), new real-world U.S. claims data presented at…